✦ LIBER ✦

Efficacy, safety and tolerability of a higher-dose 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease with and without concomitant memantine use

✍ Scribed by Grossberg, George; Farlow, Martin; Meng, Xiangyi; Somogyi, Monique

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of high-dose 13.3mg/

✍ Grossberg, G.; Farlow, M.; Meng, X.; Somogyi, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

High-dose 13.3mg/24h rivastigmine patch

✍ Molinuevo, J.L.; Cummings, J.; Frölich, L.; Galvin, J.; Krahnke, T.; Strohmaier, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Effect of body mass index on the efficac

✍ Sadowsky, Carl; Somogyi, Monique; Frolich, Lutz; Meng, Xiangyi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A 24-week, open-label extension to the A

✍ Farlow, Martin; Grossberg, George; Sadowsky, Carl; Meng, Xiangyi; Somogyi, Moniq 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Long-term safety and efficacy of 13.3mg/

✍ Farlow, M.; Grossberg, G.; Sadowsky, C.; Meng, X.; Somgyi, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Efficacy, safety and tolerability of riv

✍ Farlow, Martin; Meng, Xiangyi; Rensch, Scott; Somogyi, Monique 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB